Anika Therapeutics Inc (ANIK)

EBITDA Growth

291.57%

Quarterly · Period ending:

ANIK logo

ANIK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported291.57%
ANIK Quarterly EBITDA YoY % (-25.00% → 291.57%)
High-resolution chart · PNG

ANIK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-1,226.1881%
-288.229%
1,084.8675%
-182.5705%
-188.8273%
-75%
-100%
-88.8883%
0%
-74.1935%
400%
320%
100%
487.5%
60%
183.3333%
130%
-100%
37.5%
-50%
-900%
0%
-100%
20%
50%
-300%
20%
-25%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.